Volume : 10, Issue : 10, October – 2023
Title:
COMPARISON OF THE EFFICACY OF CONTINUOUS TERLIPRESSIN INFUSION VERSUS INTERMITTENT BOLUS ADMINISTRATION IN PATIENTS WITH ACUTE VARICEAL BLEEDING DUE TO PORTAL HYPERTENSION
Authors :
Asim Hassan , Muhammad Tariq, Zahra Iqbal, Mohammad Ali, Zafar Iqbal, Sohaib Azhar
Abstract :
Background: Acute upper gastrointestinal bleed (AUGIB) is one of the most common medical emergencies in the UK, with an estimated incidence of 134 per 100,000, roughly equating to one presentation every 6 min [1]. Despite advances in therapeutics and endoscopy provision, mortality following AUGIB over the last two decades has remained high, with over 9,000 deaths annually in the UK [2]. Patients with suspected variceal haemorrhage should be considered for prompt administration of variceal hemorrhage measures, terlipressin (or an alternative) and antibiotics.3 Terlipressin (triglycyl-lysine vasopressin), a long-acting synthetic analogue of arginine vasopressin, has been used in the treatment of variceal bleeding in patients with end-stage liver disease and paracentesis-induced circulatory dysfunction with tense ascites as well as hepatorenal syndrome. The purpose of this study is to compare the efficacy (in preventing re-bleeding) of continuous terlipressin infusion versus intermittent bolus administration in patients with acute variceal bleeding due to portal hypertension. As routinely intermittent terlipressin bolus administration in acute variceal bleeding is used in our setups, so my study will be a useful addition in this regard as we are evaluating the efficacy of continuous infusion as compared to intermittent bolus administration for preventing re-bleeding. Then on the basis of these results, some practical recommendations can be made in our routine practice guidelines to reducing re-bleeding in these particular patients.
Materials & Methods: The study was conducted at the Department of Gastroenterology, Holy Family Hospital, Rawalpindi from 28th June 2022 to 27th March 2023. It was a Randomized controlled trial. A total of 106 patients with acute variceal bleeding due to portal hypertension of age 18-70 years of either gender were included. Patients with HCC, renal failure (assessed on history and s/creatinine >1.5 mg/dl), hypersensitivity to terlipressin, acid peptic disease (assessed on history) and with upper GIT bleed with sources other than esophageal varices confirmed on endoscopy were excluded. Group A received 1 mg intravenous bolus of terlipressin followed by a continuous infusion of 4 mg in 24 h. Group B received 2 mg intravenous bolus of terlipressin followed by 1 mg intravenous injection every 6 h. In both groups, all patients were undergone endoscopy and band ligation within 24 hours of admission. History of re-bleed was taken. Results: The mean age of patients in group A was 53.30 ± 10.45 years and in group B was 55.70 ± 10.19 years. Majority of the patients 87 (82.08%) were between 46 to 70 years of age. Out of these 106 patients, 57 (53.77%) were males and 49 (46.23%) were females with male to female ratio of 1.1:1. Efficacy in terms of no re-bleeding within one month was 47 (88.68%) in group A (continuous terlipressin infusion) and 33 (62.26%) in group B (intermittent terlipressin bolus administration) with p-value of 0.002.
Conclusion: This study concluded that efficacy of continuous terlipressin infusion is better in patients with acute variceal bleeding due to portal hypertension as compared to intermittent bolus administration.
Keywords: upper gastrointestinal bleeding, continuous terlipressin infusion, portal hypertension.
Cite This Article:
Please cite this article in press Asim Hassan et al, Comparison Of The Efficacy Of Continuous Terlipressin Infusion Versus Intermittent Bolusadministration In Patients With Acute Variceal Bleeding Due To Portal Hypertension, Indo Am. J. P. Sci, 2023; 10 (10).
Number of Downloads : 10
References:
1. Alatise OI, Aderibigbe AS, Adisa AO, Adekanle O, Agbakwuru AE, Arigbabu AO. Management of overt upper gastrointestinal bleeding in a low resource setting: a real world report from Nigeria. BMC Gastroenterol. 2014;14(1):210.
2. Dewan KR, Patowary BS, Bhattarai S. A study of clinical and endoscopic profile of acute upper gastrointestinal bleeding. Kathmandu Uni Med J. 2015;12(1):21-5.
3. Papadakis MA, Mcphee SJ. Current Medical Diagnosis and treatment 55th Edition, McGrawhill Education; 2016;584-7.
4. McQuaid KR. Gastrointestinal disorders. In: Papadakis MA,McPhee SJ, Rabow MW, editors. Current medical diagnosis and treatment. 52nd Ed. New York: McGraw-Hill; 2013:564-661.
5. Elwakil R, Reda MA, Abdelhakam SM, Ghoraba DM, Ibrahim WA. Causes and outcome of upper gastrointestinal bleeding in emergency endoscopy unit of Ain Shams University Hospital. J Egypt Soc Parasitol. 2011;41:455-67.
6. Hadayat R, Jehangiri A, Gul R, Khan AN, Said K, Gandapur A. Endoscopic findings of upper gastrointestinal bleeding in patients with liver cirrhosis. J Ayub Med Coll Abbottabad. 2015;27(2):391–4.
7. National Confidential Enquiry into Patient Outcome and Death (NCEPOD). Time to get control? A review of the care received by patients who had a severe gastrointestinal haemorrhage. 2015. http://www. ncepod.org.uk/2015report1/downloads/TimeToGetControlFullReport.pdf.
8. Siau K, Chapman W, Sharma N, Tripathi D, Iqbal D, Bhala N. Management of acute upper gastrointestinal bleeding: an update for the general physicians. J R Coll Physicians Edinb. 2017;47:218–30.
9. Gralnek I, Dumonceau J, Kuipers E. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2015;47: 1–46.
10. Xinmiao Z, Dhiraj T, Tingxue S, Lichun S, Bing H, Jia Z, et al. Terlipressin for the treatment of acute variceal bleeding: a systematic review and meta-analysis of randomized controlled trials. Medicine. 2018;97(48):e13437.
11. Cavallin M, Piano S, Romano A, Fasolato S, Frigo AC, Benetti G, et al. Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study. Hepatol. 2016;63:983-92.
12. Cavallin M, Kamath PS, Merli M, Fasolato S, Toniutto P, Salerno F, et al. Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial. Hepatol. 2015;62:567-74.
13. Papaluca T, Gow P. Terlipressin – current and emerging indications in chronic liver disease. J Gastroenterol Hepatol 2018;33:591–8.
14. Jha SK, Mishra M, Jha A, Dayal VM. Comparison of continuous versus intermittent infusions of terlipressin for the control of acute variceal bleeding in patients with portal hypertension: An open-label randomized controlled trial. Indian J Gastroenterol. 2018;37(4):313-20.
15. Ioannou G, Doust J, Rockey DC. Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev. 2003;(1):CD002147
16. Fallah MA, Prakash C, Edmundowicz S. Acute gastrointestinal bleeding. Med Clin North Am. 2000 Sep. 84(5):1183-208.
17. Bolognesi M, Balducci G, Garcia-Tsao G, Gatta A, Gines P, Merli M, et al. Complications in the medical treatment of portal hypertension. Portal Hypertension III. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and therapeutic Strategies.Oxford,UK:Blackwell Science, 2001:180-203.
18. D’Amico G, Pagliaro L, Bosch J, Pharmacological treatment of portal hypertension: an evidence based approach. Semin Liver Dis 1999;19:475-505.
19. Morelli A, Ertmer C, Lange M, Westphal M. Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better? Intensive Care Med 2007;33:1669-1670.
20. D’Amico G, Pagliaro L, Bosch J, Pharmacological treatment of portal hypertension: an evidence based approach. Semin Liver Dis 1999;19:475-505.
21. Morelli A, Ertmer C, Lange M, Westphal M. Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better? Intensive Care Med 2007;33:1669-1670.